About BOS complex subunit NCLN
BOS complex subunit NCLN (NCLN) is a protein
from Homo sapiens identified by UniProt accession
Q969V3, 563 residues long.
MolForge cross-references it against 0 known binders and
36 disease associations.
Target properties
| Protein name | BOS complex subunit NCLN |
| UniProt accession | Q969V3 |
| Gene | NCLN |
| Organism | Homo sapiens |
| Length | 563 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (36)
Diseases linked to this target (Open Targets).
- neutrophil count · score 0.27
- Hirschsprung disease · score 0.26
- basophil percentage of leukocytes · score 0.25
- neutrophil percentage of leukocytes · score 0.24
- leukocyte count · score 0.23
- monocyte count · score 0.21
- myeloid white cell count · score 0.20
- mean corpuscular hemoglobin · score 0.14
- eosinophil count · score 0.13
- lymphocyte percentage of leukocytes · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q969V3-F1 | alphafold | PREDICTED | 85.40 | — |
Amino-acid sequence (563 residues)
MLEEAGEVLE NMLKASCLPL GFIVFLPAVL LLVAPPLPAA DAAHEFTVYR MQQYDLQGQP YGTRNAVLNT EARTMAAEVL SRRCVLMRLL DFSYEQYQKA LRQSAGAVVI ILPRAMAAVP QDVVRQFMEI EPEMLAMETA VPVYFAVEDE ALLSIYKQTQ AASASQGSAS AAEVLLRTAT ANGFQMVTSG VQSKAVSDWL IASVEGRLTG LGGEDLPTIV IVAHYDAFGV APWLSLGADS NGSGVSVLLE LARLFSRLYT YKRTHAAYNL LFFASGGGKF NYQGTKRWLE DNLDHTDSSL LQDNVAFVLC LDTVGRGSSL HLHVSKPPRE GTLQHAFLRE LETVAAHQFP EVRFSMVHKR INLAEDVLAW EHERFAIRRL PAFTLSHLES HRDGQRSSIM DVRSRVDSKT LTRNTRIIAE ALTRVIYNLT EKGTPPDMPV FTEQMQIQQE QLDSVMDWLT NQPRAAQLVD KDSTFLSTLE HHLSRYLKDV KQHHVKADKR DPEFVFYDQL KQVMNAYRVK PAVFDLLLAV GIAAYLGMAY VAVQHFSLLY KTVQRLLVKA KTQ
Explore BOS complex subunit NCLN with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets